Sputnik V recommended for emergency use

  • IASbaba
  • April 13, 2021
  • 0
UPSC Articles
Print Friendly, PDF & Email

Sputnik V recommended for emergency use

Part of: GS Prelims and GS – II – Health 

In news

  • Russia’s COVID-19 vaccine — Sputnik V — has been recommended for emergency use authorisation in India following a meeting of the Subject Expert Committee (SEC).

Key takeaways 

  • If approved by the Drug Controller General of India (DCGI), Sputnik V would be the third vaccine to be made available in India after the Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin.
  • Sputnik V is developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology
  • It claims to be one of the three vaccines in the world with efficacy of over 90%.
  • The vaccine supplies for the global market will be produced by the Russian Direct Investment Fund (RDIF) international partners in India, Brazil, China, South Korea and other countries.

Search now.....

Sign Up To Receive Regular Updates